Nervous System Diseases

>

Latest News

FDA Awards Accelerated Approval to Aducanumab for Alzheimer Disease
FDA Awards Accelerated Approval to Aducanumab for Alzheimer Disease

June 7th 2021

The FDA approved today the first drug that targets the pathophysiolgic process responsible for Alzheimer disease and the first drug since 2003 to be approved for any Alzheimer treatment.

FDA Warns Lamotrigine May Cause Arrhythmias in Persons with Heart Disease
FDA Warns Lamotrigine May Cause Arrhythmias in Persons with Heart Disease

April 2nd 2021

Seen in the ED: Dysphagia & Floppy Neck
Seen in the ED: Dysphagia & Floppy Neck

March 12th 2021

Proton Pump Inhibitors Linked to Cognitive Decline

June 21st 2016

PPIs and Dementia: Is Causality Really There?
PPIs and Dementia: Is Causality Really There?

April 15th 2016

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.